Pimecrolimus en es it fr

Pimecrolimus Brand names, Pimecrolimus Analogs

Pimecrolimus Brand Names Mixture

  • No information avaliable

Pimecrolimus Chemical_Formula


Pimecrolimus RX_link


Pimecrolimus fda sheet

Pimecrolimus FDA

Pimecrolimus msds (material safety sheet)

Pimecrolimus Synthesis Reference

No information avaliable

Pimecrolimus Molecular Weight

810.453 g/mol

Pimecrolimus Melting Point

No information avaliable

Pimecrolimus H2O Solubility

No information avaliable

Pimecrolimus State


Pimecrolimus LogP


Pimecrolimus Dosage Forms


Pimecrolimus Indication

For treatment of mild to moderate atopic dermatitis.

Pimecrolimus Pharmacology

Pimecrolimus is a chemical that is used to treat atopic dermatitis (eczema). Atopic dermatitis is a skin condition characterized by redness, itching, scaling and inflammation of the skin. The cause of atopic dermatitis is not known; however, scientists believe that it may be due to activation of the immune system by various environmental or emotional triggers. Scientists do not know exactly how pimecrolimus reduces the manifestations of atopic dermatitis, but pimecrolimus reduces the action of T-cells and mast cells which are part of the immune system and contribute to responses of the immune system. Pimecrolimus prevents the activation of T-cells by blocking the effects of chemicals (cytokines) released by the body that stimulate T-cells. Pimecrolimus also reduces the ability of mast cells to release chemicals that promote inflammation.

Pimecrolimus Absorption

Because of the low systemic absorption of pimecrolimus following topical application the calculation of standard pharmacokinetic measures such as AUC, Cmax, half-life, etc. cannot be reliably done.

Pimecrolimus side effects and Toxicity

Side effects include burning sensation, irritation, pruritus, erythema, and skin infections, at the application site.

Pimecrolimus Patient Information

Pimecrolimus Organisms Affected

Humans and other mammals